111 South 11th Street
Room G-301, Bodine Center
Philadelphia, PA 19107
(215) 955-6702
(215) 955-0412 fax
Room G-301, Bodine Center
Philadelphia, PA 19107
(215) 955-6702
(215) 955-0412 fax
Most Recent Peer-reviewed Publications
- Radiation therapy use and outcomes among older women with ER-positive and ER-negative stage I breast cancer
- Head and neck carcinoma in the United States: First comprehensive report of the Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN)
- Implementation and experimental results of 4D tumor tracking using robotic couch
- Conditional survival probabilities for patients with resected pancreatic adenocarcinoma
- Assessing the value of an optional radiation oncology clinical rotation during the core clerkships in medical school
- Phase I trial using the proteasome inhibitor bortezomib and concurrent chemoradiotherapy for head-and-neck malignancies
- Radiation therapy oncology group 0247: A randomized phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer
- Toxicities after radioembolization with yttrium-90 SIR-spheres: Incidence and contributing risk factors at a single center
- The Influence of Prognostic Factors and Adjuvant Chemoradiation on Survival After Pancreaticoduodenectomy for Ampullary Carcinoma
- Side-branch embolization before 90Y radioembolization: Rate of recanalization and new collateral development
- Reirradiation of head and neck cancer with high-dose-rate brachytherapy: A customizable intraluminal solution for postoperative treatment of tracheal mucosa recurrence
- Radioembolization as salvage therapy for hepatic metastasis of uveal melanoma: A single-institution experience
- Does diabetes mellitus influence pathologic complete response and tumor downstaging after neoadjuvant chemoradiation for esophageal and gastroesophageal cancer? A two-institution report
- Randomized phase II trial evaluating two paclitaxel and cisplatin-containing chemoradiation regimens as adjuvant therapy in resected gastric cancer (RTOG-0114)
- Pretreatment FDG-PET standardized uptake value as a prognostic factor for outcome in head and neck cancer
- Distinguishing post-treatment changes from recurrent disease in cholangiocarcinoma: A case report
- Neck dissection followed by chemoradiotherapy for stage IV (N+) oropharynx cancer
- A Phase II trial of subcutaneous amifostine and radiation therapy in patients with head-and-neck cancer
- Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): Quality of combined modality therapy and pathologic response
- Impact of Her-2 neu overexpression on outcome of elderly women treated with wide local excision and breast irradiation for early stage breast cancer: An exploratory analysis